Pharmacotherapy of Rare Diseases in Serbia: The Current State of Art
Rare diseases affect less than 1 in 2000 or 5 in 10,000 people by definition. Most of those diseases have genetic basis (80% of cases) and first symptoms appear in early childhood (50% of cases). Most of these diseases are chronic and degenerative and pharmacotherapy is not available for many of the...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2020
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/71130 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Pharmacotherapy of Rare Diseases in Serbia: The Current State of Art
- Population Pharmacokinetic Analysis of Therapeutic Drug Monitoring Data in Optimizing Pharmacotherapy of Antiepileptic Drugs
- Cost of outpatient hypertension pharmacotherapy: comparative study between Bulgaria and Serbia.
- Air Radioactivity Monitoring in Serbia
- Identidad cultural. La película etnográfica en Serbia
- Discovering Lyme Disease in Ticks and Dogs in Serbia – Detection and Diagnostic Methods
- The Pharmacotherapy of Corticosteroids